University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment : Therapeutic Advances in Respiratory Disease

dc.contributor.authorvan Geer-Postmus,  Iris
dc.contributor.authorLeving,  Marika T.
dc.contributor.authorGerritsma,  Yoran H.
dc.contributor.authorBaan,  Esmé
dc.contributor.authorDijk,  Lars
dc.contributor.authorHarms,  Evelien
dc.contributor.authorPrice,  David
dc.contributor.authorPrins,  Gerian H.
dc.contributor.authorQuint,  Jennifer K.
dc.contributor.authorRyan,  Dermot
dc.contributor.authorSalomé,  Philippe
dc.contributor.authorStällberg,  Björn
dc.contributor.authorStoker,  Nilouq
dc.contributor.authorKocks,  Janwillem H.
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2025-06-05T13:22:01Z
dc.date.available2025-06-05T13:22:01Z
dc.date.issued2025-12
dc.descriptionWe like to thank all participating general practitioners for using the CodeX Asthma or COPD report and sharing the data for research purposes. The following general practitioners participated: R.A. Riemersma, Appingedam; GP Practice Geulle (J. Muris), Geulle; Wind en van der Werf, Hoogezand; R. Boersma, Groningen; Veendokters, Barger-Compascuum; De Held (E. Visser), Groningen; T. Van Pelt, Meppel; de Noord-Ooster (D. Rezelman), Wagenborgen; het Kruispunt (A.F.M. Spreeuw), Vlaardingen. Also, we like to thank Topicus for their collaboration and support in the development of the CodeX reports.en
dc.description.statusPeer revieweden
dc.format.extent8
dc.format.extent511843
dc.identifier304475860
dc.identifier86b5d726-38ac-46d3-b848-50ee15f868fa
dc.identifier105004335586
dc.identifier.citationvan Geer-Postmus, I, Leving, M T, Gerritsma, Y H, Baan, E, Dijk, L, Harms, E, Price, D, Prins, G H, Quint, J K, Ryan, D, Salomé, P, Ställberg, B, Stoker, N & Kocks, J H 2025, 'CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment : Therapeutic Advances in Respiratory Disease', Therapeutic advances in respiratory disease, vol. 19, 17534666251329192. https://doi.org/10.1177/17534666251329192en
dc.identifier.doi10.1177/17534666251329192
dc.identifier.issn1753-4658
dc.identifier.otherRIS: urn:2D9AC37D19A27FA25481EC015A453D08
dc.identifier.urihttps://hdl.handle.net/2164/25539
dc.identifier.vol19en
dc.language.isoeng
dc.relation.ispartofTherapeutic advances in respiratory diseaseen
dc.subjectalgorithmen
dc.subjectasthmaen
dc.subjectcardiopulmonary pathwayen
dc.subjectCOPDen
dc.subjectexacerbationsen
dc.subjectlung attacksen
dc.subjectquality improvementen
dc.subjecttreatment optimalizationen
dc.subjectR Medicine (General)en
dc.subjectSupplementary Informationen
dc.subject.lccR1en
dc.titleCodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment : Therapeutic Advances in Respiratory Diseaseen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Postmus_etal_TARD_CodeX_Effectively_Identifies_VOR.pdf
Size:
499.85 KB
Format:
Adobe Portable Document Format

Collections